During the past decade, Tel Aviv Sourasky Medical Ctr; Oncology conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 11 clinical trials were completed, i.e. on average, 52.4% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 8 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tel Aviv Sourasky Medical Ctr; Oncology" #1 sponsor was "Hoffmann-La Roche" with 23 trials, followed by "Central European Cooperative Oncology Group" with 2 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Kartos Therapeutics, Inc." with 1 trials sponsored and "NovoCure Ltd." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tel Aviv Sourasky Medical Ctr; Oncology" #1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Clalit Health Services" with 1 trials as a collaborator, "Foundation Medicine, Inc." with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Tel Aviv Sourasky Medical Ctr; Oncology" are "Breast Cancer" (6 trials), "Colorectal Cancer" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Adenocarcinoma" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Tel Aviv Sourasky Medical Ctr; Oncology" in a lesser frequency.

Most popular intervention types in "Tel Aviv Sourasky Medical Ctr; Oncology" are "Drug" (28 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (9 trials), "Docetaxel" (8 trials), "Paclitaxel" (8 trials), "Carboplatin" (7 trials) and "Gemcitabine" (6 trials). Other intervention names were less common.

The vast majority of trials in "Tel Aviv Sourasky Medical Ctr; Oncology" are 28 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Tel Aviv Sourasky Medical Ctr; Oncology". undefined are not yet recruiting, 10 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Tel Aviv Sourasky Medical Ctr; Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tel Aviv Sourasky Medical Ctr; Oncology, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".